CAS 2049868-46-2

GSK'963

CAS : 2049868-46-2

Formule : C₁₄H₁₈N₂O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 230.3055

Ref: IN-DA01FW4O

(S)-2,2-Dimethyl-1-(5-Phenyl-4,5-Dihydro-1H-Pyrazol-1-Yl)Propan-1-One

CAS : 2049868-46-2

(S)-2,2-Dimethyl-1-(5-Phenyl-4,5-Dihydro-1H-Pyrazol-1-Yl)Propan-1-One

Degré de pureté : 99%

Masse moléculaire : 230.31g/mol

Ref: 54-OR1024299

GSK963

CAS : 2049868-46-2

GSK963

Degré de pureté : ≥95%

Masse moléculaire : 230.31g/mol

Ref: 54-BUP04014

GSK963

CAS : 2049868-46-2

GSK963 (Racemate), a structurally distinct, potent and selective inhibitor of RIP1 kinase(IC50=29 nM).

Formule : C₁₄H₁₈N₂O

Degré de pureté : 98.00%

Couleur et forme : Solid

Masse moléculaire : 230.31

Ref: TM-T5054

GSK'963

CAS : 2049868-46-2

GSK'963 is a selective inhibitor, which is a pharmacological agent primarily targeting the receptor-interacting protein kinase 1 (RIP1). Originating from GlaxoSmithKline's research efforts, this inhibitor is a synthetic compound designed to interfere with specific biochemical pathways. GSK'963 operates by targeting the RIP1 kinase, a crucial component involved in necroptosis, a form of programmed cell death distinct from apoptosis.

Formule : C₁₄H₁₈N₂O

Degré de pureté : Min. 95%

Masse moléculaire : 230.31 g/mol

Ref: 3D-ZGD86846